News for hackers. Stuff that matters.
Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by isitmadeofglass on Friday November 18, 2022 @03:34PM (#33661667)
The patent has expired anyone can make insulin cheaper if they want to. The new drugs on patent (many set to expire in the short term future) are all improvements that greatly improve quality of life for patients which is why they are preferred to just using human insulin.
Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by 6nf on Friday November 18, 2022 @04:55PM (#33662905)
Why is it so much cheaper in countries other than the USA?
Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by s1artibartfast on Friday November 18, 2022 @05:24PM (#33663308)
Higher cost of labor and customers have more money to spend
Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by palmetieri2000 on Friday November 18, 2022 @05:58PM (#33663933)
Than in Europe, Australia, and the UK? Laughable.
Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by s1artibartfast on Friday November 18, 2022 @06:01PM (#33664001)
Why is that laughable, US has a higher median and mean income than nearly all of Europe, Austrialia, and the UK.

This means workers cost more and have more.

Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by palmetieri2000 on Saturday November 19, 2022 @12:40AM (#33667313)
According to the first google results this is not true for the US and Australian comparison, even after converting AUD to USD the Australian worker makes about $2000 more than the US worker.

You also fail to recognize that US workers spend more to achieve similar healthcare outcomes, something highly relevant to this conversation.

Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by expazl on Friday November 18, 2022 @06:06PM (#33664079)
Both wrong. Labor costs are high in Europe too, and people have as much money to spend. Also, if that was the reason, American patients would just buy the European products since they where cheaper. Also the drugs sold on the two sides of the Canadian border are produced the same places but sell at much lower prices outside the US.

The reason the North American market is so expensive is because of convoluted and honestly just shady practices of middlemen who negotiate on behalf of insurances companies and pharmacies but have a vested interest in pushing the list price as high as possible, but then demanding an insane rebate against those high list prices. During the congressional hearings it was stated that Eli Lilly paid something like 68% in rebates in order to get onto the insurance coverage plans. Also, even though their prices where rising year after year, they took back less and less after rebates where figured in. That means that whenever Eli Lilly sells 100$ worth of insulin, 22$ goes towards research and development, clinical trials, branding, marketing, production and distribution, and then 68$ goes to the pharmacy benefits managers who kick it back to the insurance companies, who then go to their customers and demand a copay as a percentage of the 100$ potentially not even needing to cover anything and just making bank on the drug sales, while charging their customers for the privilege of taking their money.

Re:Eli Lilly CEO says insulin tweet flap “probably” signals ... by s1artibartfast on Friday November 18, 2022 @06:28PM (#33664411)
I don't necessarily disagree, but was answering from the perspective of generic insulin purchased without insurance.

Why is Insulin aspart $70 for 1,000 units at walmart, but much cheaper in India.